Barbados vs Brunei: Cause of death, by non-communicable diseases, ages 60+
Barbados
83.7%
in 2021
Brunei
83.5%
in 2021
Barbados rank
28th
Brunei rank
29th
Cause of death, by non-communicable diseases, ages 60+ over time
- Barbados
- Brunei
How they compare
Barbados currently reports 83.7% against 83.5% in Brunei, a difference of 0.2%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Brunei ahead.
Barbados ranks 28th and Brunei ranks 29th of 185 countries.
Across the 3 decades both report, Barbados averaged higher in 2 and Brunei in 1.
Head to head by decade
| Decade | Barbados | Brunei | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 90.6% | 91.7% | 1.0% | Brunei |
| 2010s | 90.6% | 86.5% | 4.1% | Barbados |
| 2020s | 87.5% | 84.9% | 2.6% | Barbados |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, Barbados or Brunei?
- Barbados, at 83.7% against 83.5% in Brunei as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+ between Barbados and Brunei?
- 0.2%, with Barbados ahead.
- How many years of comparable data are there for Barbados and Brunei?
- 6 years are reported by both, from 2000 to 2021.
- How do Barbados and Brunei rank globally for cause of death, by non-communicable diseases, ages 60+?
- Barbados ranks 28th and Brunei ranks 29th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+ (% of total deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 60+ due to non-communicable diseases divided by number of all deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.